Four Verdicts in Ten Days. The Last One Pays 51%.

Nothing happened. That’s the story. Neither Allied Gold nor Zijin has disclosed a word since the June 10 reaffirmation, and this week the market simply stopped waiting — the spread exploded from 33.4% to 51.4%, pricing NDRC approval as a coin flip or worse with the July 29 outside date ten days out. The stock now trades around C$29 against a C$44 all-cash offer.

Two structural facts temper the cliff-edge read. Ethiopia’s clearance this month completed every single approval outside China — the deal is now literally Beijing-or-bust. And reports indicate the arrangement contemplates a possible further extension to September 29 if both parties agree, which would make July 29 a checkpoint rather than a cliff. The honest framing: nobody outside the NDRC knows anything, both parties remain publicly committed, and at 51% this is a pure binary priced for failure — extraordinary if Zijin’s commitment converts, brutal if it doesn’t. Size like the coin flip it is.

No NYDFS news. No company statements since the June 24 joint update. And yet the spread nearly doubled from 10.3% to 19.2%. This is the fork we reframed in early July playing out in the price: the question was never really whether NYDFS says no — outright denials are rare; delay and conditional approval are the norm — it’s whether Western Union still says yes. The merger agreement obligates WU to accept no remedies, the $27.3M break fee triggers only on antitrust restraints, and Intermex’s EBITDA is running ~40% below what WU underwrote. With WU’s own shares near multi-year lows, the market is now paying real attention to buyer incentives.

The next hard information is earnings: WU’s Q2 call in late July (listen to the deal-appetite tone), then Intermex’s in early August. The August 10 automatic outside-date extension to November 10 is the procedural backstop. At ~$13.40 vs $16.00, the odds-adjusted math has improved if you believe the June recommitment — but the ~45% break downside is unchanged, and the market just told you how much weight it puts on that branch.

The EC’s Phase 1 decision on the committed UIP exit lands Wednesday, July 22 — and Brussels is reportedly minded to clear. That would resolve the biggest formal gate left and shift the entire residual story to the UK, which drifted worse this week: Parliament rose for summer recess with Culture Secretary Nandy still silent on a formal intervention, 17 days after “minded to intervene” (the Fox/Sky precedent took 10). A government-ordered investigation would almost certainly run past Paramount’s September 30 closing target — triggering the 25¢/share/quarter ticking fee, roughly $650M per quarter, payable to WBD holders.

One nuance the market may be underweighting: the UK regime is non-suspensory — the merger can legally close without UK clearance. Whether Paramount would actually wait out a five-month Phase 2 while writing $650M quarterly checks is a genuine question, and the economic pressure runs entirely one direction. Analysts call Nandy “process, not a problem”; nobody serious expects a veto. Wednesday first.

The gloves are off. Diana extended the tender to July 24 with 11.08M shares in (29.7% of the outside float, up from 28.4%), Paliou conceded the deal “cannot move forward through a tender offer alone,” and Genco’s board unanimously rejected again — accusing Diana of arguing “petty technicalities” while pointedly noting the formal tender is still $24.80 cash because the promised F-4 formalizing the $27.34 cash-plus-stock terms hasn’t been filed. Diana’s response was a release literally headlined “Why is Genco So Afraid of Diana’s Tender Offer?”

The spread doubled from 5.5% to 11.2% as the market marked down negotiated-endgame odds. The mechanics still favor patience over panic: ~30% of the outside float is publicly pressuring a board that owes them no mechanism, Diana’s $1.4B financing is committed, and the F-4 — when it finally lands — converts the sweetener from rhetoric into paper. Friday’s count tells us whether shareholder pressure is still building.

Rocket Lab’s ~$8B acquisition of Iridium is the tracker’s only collar deal, and it’s now the fourth-widest spread on the board — so here’s how the machine works. Each IRDM share gets $27.00 cash plus RKLB stock targeting another $27.00: while RKLB’s 10-day VWAP sits between $67.50 and $112.50, the exchange ratio floats to hold the package at $54.00 flat — inside that band, RKLB’s daily swings don’t touch the deal value at all. At or below $67.50 the ratio freezes at 0.4000 and consideration falls with RKLB; above $112.50 it freezes at 0.24 and rises.

The live drama could not be more literal: RKLB closed Friday at ~$67.60 — ten cents above the floor. At the boundary the two regimes converge (0.40 × $67.50 = $27.00 exactly), so nothing breaks mechanically at the line — but below it, IRDM holders own 0.40 RKLB plus cash, with RKLB downside and no cap release until $112.50 on the way back up. The saving grace is timing: the contractual measurement is a 10-day VWAP ending two trading days before a mid-2027 close, so Friday’s print is the market’s stress signal, not the measurement — RKLB has nearly a year to trade back into the band (S-4, HSR, FCC and the stockholder meeting all lie ahead; $3.6B bridge financing). That conditional exposure — no hedge needed inside the band, a 0.40-ratio hedge below it — is the classic collar problem, and it’s why this spread pays 16% when simpler deals pay 2%. The one number to watch is no longer approaching. It’s here.

XOMA closed July 14 (Ligand, $39.00 + the Janssen-litigation CVR, which lives on post-close). Sila Realty completed at $30.38 (Blue Owl). Catalyst Pharmaceuticals closed at $31.50 (Angelini — the deal that walked from $27+CVR to $31.50 all-cash). Emerald closed at $5.03 (Apollo, via Onex’s 93% written consent — no vote ever needed). Whitestone REIT completed (Ares, all-cash). Six more deals sit pinned within a point of their offers — the conveyor belt continues, and new deal announcements aren’t replacing closings one-for-one. A shrinking opportunity set is its own market signal.